Cite
HARVARD Citation
Haaker, L. et al. (2019). Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors. Acta clinica belgica. 74 (6), pp. 414-423. [Online].